Ilana Schlam: Happy to Share Our Review on ctDNA in Early Breast Cancer
Ilana Schlam/X

Ilana Schlam: Happy to Share Our Review on ctDNA in Early Breast Cancer

Ilana Schlam, Breast medical oncologist at Dana-Farber Cancer Institute, shared a post on X:

”Happy to share our review on ctDNA in early breast cancer. We discuss current evidence, clinical applications, challenges, and future directions.”

Title: Circulating Tumor DNA in Early Breast Cancer

Authors: Ilana Schlam, Sara M. Tolaney, Nancy U. Lin, Heather Parsons, Stefania

Read The Full Article.

Ilana Schlam: Happy to Share Our Review on ctDNA in Early Breast Cancer

WSG TP-II Trial: Excellent 5-Year Survival After De-Escalated Neoadjuvant Therapy In HR+/HER2+ Early Breast Cancer
Ilana Schlam: Happy to Share Our Review on ctDNA in Early Breast Cancer